Usage Scenarios

·Suitable for activation and mass expansion of different immune cells such as NK cells, CAR-NK cells and TIL.

·Process Development Stage: Evaluate the in vitro expansion capacity of cells such as NK and TIL and optimize the process during the early development stage of cell therapy products.

·Process locking, product production and comparability study phase: During the mid-term process locking, production and cell process change phase after IND approval for cell therapy products, establish stable cell expansion processes based on trophoblast cells, such as NK and TIL, and carry out process locking, cellular drug production and comparability studies for cell products.

Performance Indicators

Data Presentation

Fold expansion and viability of different Donor-derived NK cells

Purity of different Donor-derived NK cells